Adaptive Aerosol Delivery (AAD®) technology

Expert Opinion on Drug Delivery

Volumn 1, Issue 1, 2004, Pages 165-176

  Denyer, J ^b   Nikander, K ^a   Smith, N J ^b  

^a Respironics   (United States)

^b Profile Therapeut a Respironics Co   (United Kingdom)

Author keywords

AAD system; Adaptive Aerosol Delivery; HaloLite ; I neb; Nebuliser; Prodose

Indexed keywords

ANTIBIOTIC AGENT; BUDESONIDE; COLISTIN; CORTICOSTEROID; DEOXYRIBONUCLEASE; ILOPROST; PENTETIC ACID; PLACEBO; SALBUTAMOL; TERBUTALINE;

AEROSOL; ARTICLE; ASTHMA; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; EMPHYSEMA; FEEDBACK SYSTEM; HUMAN; IN VITRO STUDY; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; PATIENT COMPLIANCE; PULMONARY HYPERTENSION; RESPIRATORY TRACT DISEASE;

ADMINISTRATION, INHALATION; AEROSOLS; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; LUNG DISEASES; NEBULIZERS AND VAPORIZERS; PHARMACEUTICAL PREPARATIONS; TECHNOLOGY, PHARMACEUTICAL;

EID: 14544277970     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.1.1.165     Document Type: Article

References (29)

1. O'CALLAGHAN C, BARRY PW: The Science of nebulised drug delivery. Thorax (1997) 52 (Suppl 2):S31-S44.
2. NIKANDER K, DENYER J: Breathing patterns. Eur. Respir. Rev. (2000) 10 (76):576-579.
3. NIKANDER K: Drug delivery systems. J. Aerosol Med. (1994) 7:S19-S24.
4. COCHRANE GM, HORNE R, CHANEZ P: Compliance in asthma. Respir. Med. (1999) 93:763-769.
5. NIKANDER K: Adaptive aerosol delivery: the principles. Eur. Respir. Rev. (1997) 7:385-387.
6. DENYER J: Adaptive aerosol delivery in practise. Eur. Respir. Rev. (1997) 7:388-389.
7. YOUNG JP, HATLEY RHM, NIKANDER K: Consistent drug delivery with the new prodose adaptive aerosol delivery (AAD) system, an in vitro study. J. Aerosol Med. (2003) 16(2):192.
8. NIKANDER K, DENYER J, SMALDONE GC: Effects of equipment dead space and pediatric breathing patterns on inhaled mass of nebulized budesonide. J. Aerosol Med. (1999) 12(2):67-73.
9. NIKANDER K, DENYER J, EVERARD M, SMALDONE GC: Validation of a new breathing simulator generating and measuring inhaled aerosol with adult breathing patterns. J. Aerosol Med. (2000) 13 2):139-146.
10. DYCHE A, LASHAM N, DENYER J: In vitro characterisation of the HaloLite adaptive aerosol delivery (AAD) system. Proceedings of Drug Delivery to the Lung IX. The Aerosol Society, London, UK (1998):14-15.
11. HARDAKER LE, IBANEZ E, HATLEY RHM: In vitro determination of flexible dosing achieved using the new Prodose Disc. Proceedings of Drug Delivery to the Lung XIV. The Aerosol Society, Bristol, UK. (2003):90-93.
12. DENYER J, DYCHE T, NIKANDER K, NEWMAN S, RICHARDS J, DEAN A: HaloLite a novel liquid drug aerosol delivery system. Thorax (1997) 52 (Suppl 6):A83.
13. DEVADASON SG, HUANG T, WALKER SL, TROEDSON R, LE SOUEF PN: Lung deposition of rhDNase in children with cystic fibrosis using the HaloLite adaptive aerosol delivery (AAD) system and Pari LC+ nebuliser. Proceedings of the 24th European Cystic Fibrosis Conference. Austrian Cystic Fibrosis Association and European Cystic Fibrosis Society, Vienna. June 6-9 (2001).
14. BYRNE NM, KEAVEY PM, PERRY JD, GOULD FK, SPENCER DA: Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis. Arch. Dis. Child. (2003) 88:715-718.
15. KASTELIK JA, WRIGHT GA, AZIZ I et al.: A widely available method for the assessment of aerosol delivery in cystic fibrosis. Pulmonary Pharmacology & Therapeutics (2002) 00 1-7.
16. COLDHAM CM, MULRENNAN SA, WRIGHT G, DAVIES T, SEYMOUR JD, MORICE AH: A pilot study to investigate the lung deposition of aerosol nebulised solutions using two different nebuliser system in to the lungs of cystic fibrosis (CF) patients. J. Cyst. Fibros. (2004) 3 Suppl 1):S65.
17. DENYER J, DYCHE A: Patient compliance with treatment using a novel aerosol delivery system. Proceedings of Drug Delivery to the Lung IX. The Aerosol Society, London, UK. Dec (1998):14-15.
18. IQBAL S, RITSON S, PRINCE I, DENYER J, EVERARD ML: Drug delivery and adherence in young children. Pediatr. Pulmonol. (2004) 37:311-317.
19. EVERARD M, COBOS N: Drug delivery developments. Respiratory Disease in Practice (2001) 18(2):18-20.
20. NIKANDER K, ARHEDEN L, DENYER J, COBOS N: Parents' adherence with nebulizer treatment of their children using an adaptive aerosol delivery (AAD™) system. J. Aerosol Med. (2003) 16 3):273-281.
21. BAKER JW, MELLON M, WALD J, WELCH M, CRUZ-RIVERA M, WALTON-BOWEN KA: Multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistant asthma in young children and infants. Pediatrics (1999) 103(2):414-421.
22. MARSDEN R, CONWAY S, DODD M et al.: A multi-centre, randomised study comparing the HaloLite adaptive aerosol delivery (AAD) system with a high output nebuliser system in patients with cystic fibrosis. J. Cyst. Fibros. (2002) 1 (Suppl 1):S105.
23. DODD M, CONWAY S, MARSDEN R, PAUL E, WELLER P: Interaction between bronchodilators and nebuliser device in cystic fibrosis patients taking colistin using a HaloLite adaptive aerosol delivery (AAD) system compared to a high output conventional nebuliser system. J. Cyst. Fibros. (2002) 1(Suppl. 1):S106.
24. OLSCHEWSKI H, ROHDE B, BEHR J et al.: Pharmacodynamics and pharmacokinetics of inhaled iloprost, aerosolised by three different devices, in severe pulmonary hypertension. Chest (2003) 124 1294-1304.
25. OLSCHEWSKI H, SIMONNEAU G, GALIE N et al.: Inhaled iloprost for severe pulmonary hypertension. N. Engl. J. Med. (2002) 347(5):322-329.
26. DENYER J, PRINCE I, NEWMAN S, CLARK D, CONWAY J, LODHI A: An exploratory study of lung deposition of 99mTc-DTPA radiolabelled saline when using three different breathing manoeuvres. Proceedings of Respiratory Drug Delivery IX. Palm Desert, Virginia Commonwealth University, US. April (2004):25-29.
27. PRINCE I, SEAMARK D, PINNUCK M, HINCH S, DENYER J, CONWAY J: Evaluation of a guided breathing manoeuvre for nebulised inhaled therapy. Proceedings of Respiratory Drug Delivery IX. Palm Desert, Virginia Commonwealth University, US. April (2004):25-29.
28. BARRETT M, WHIFFIN A, WEBB AK, WELLER P, STABLEFORTH D: Patient acceptance of a new adaptive aerosol delivery (AAD) system that facilitates the home delivery of medication. Pediatr. Pulmonol. (2003) (Suppl 25):320-321.
29. JACKSON W: Nebulised Pulmicort Therapy. A scientific and practical review. Oxford, UK (1998).